EcoDrugPlus

Glutamate Ionotropic Receptor Kainate Type Subunit 4

Ensembl ID : ENSTBEG00000002425
Gene Symbol: GRIK4
1 Cross references
261 Possible Orthologues:

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSTBEG00000002924
Gene Symbol: GRM2
1 Cross references
276 Possible Orthologues:

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSTBEG00000013197
Gene Symbol: GRM5
1 Cross references
272 Possible Orthologues:

Glutaminase

Ensembl ID : ENSTBEG00000017068
Gene Symbol: GLS
1 Cross references
302 Possible Orthologues:

Glutathione S-Transferase Pi 1

Ensembl ID : ENSTBEG00000007507
Gene Symbol: GSTP1
1 Cross references
172 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSTBEG00000000101
Gene Symbol: GSK3A
1 Cross references
260 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSTBEG00000001237
Gene Symbol: GSK3B
1 Cross references
241 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor

Ensembl ID : ENSTBEG00000017075
Gene Symbol: GNRHR
1 Cross references
96 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSTBEG00000011302
Gene Symbol: GHSR
1 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSTBEG00000006055
Gene Symbol: GUCY1A1
1 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSTBEG00000007318
Gene Symbol: GUCY1A2
1 Cross references
201 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSTBEG00000013399
Gene Symbol: GUCY1B1
1 Cross references
209 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).